REKA Health Pte. Ltd.

REKA Health announces new members on its scientific advisory committee

Singapore 1st June 2014

REKA Health Pte Ltd, a medical technology company that offers digital Cardiac Rhythm Monitoring solution announces that Stefano Omboni, MD (Italy) and Jeremy Chow, MD (Singapore) join its SAC as committee members. The SAC will offer their objective expert opinions in cardiovascular practice and treatment, and professional guidance on technology application and adoption in the related fields. REKA believes that its products and technology have the potential to transform the cardiac rhythm monitoring paradigm in the multi-billion dollar cardiovascular market. The SAC will remain independent to work closely with REKA's management team to shape REKA's product roadmap and technology offerings, while the SAC continues to attract the world’s leading experts in cardiovascular practice and treatment to support its own activities such as conferences to encourage collaborations among thought leaders cross the globe.

The SAC will aslo contribute to REKA’s endeavor to expand its reach in clinical research space as the advisory committee also acts as platform for opinion leaders to exchange thoughts. “It is excellent to work with some of the thought leaders in the cardiology space to look into the technology transformation for the cardiovascular clinical applications and treatment. “ said Dr. Stefano Omboni, a research cardiologist and member of SAC.

The use of REKA's solution to support research area can be traced a few years back where it was deployed in a cardiac rhythm therapeutic phase II drug trial whose result was recently announced. REKA will continue to expand in the research area seeking co-operation with pharmaceutical companies, Contract Research Organizations (CROs), Biotechnology companies and Academic Research Organizations (AROs) to further strengthen its presence and offering globally.

“The independent and objective views from the SAC serve as expert guidance and validation for REKA to deliver the world leading digital Cardiac Rhythm Monitoring solution,” said Mr. Tan Kae Yuan, Group CEO, REKA Health PTE LTD. "We believe such framework will ensure high quality system can be delivered to meet the researchers' needs."

For profiles of Dr. Stefano Omboni and Dr. Jeremy Chow, please visit Scientific Advisory Committee page (http://www.rekahealth.com/en/advisory-committee.html).